Reviews: Zotarolimus stent shows efficacy in diabetes patients

04/22/2013 | Healio

Resolute Integrity's zotarolimus-eluting stent helped reduce target vessel failure rate and proved safe and effective in patients with diabetes, an analysis revealed. Another review showed insulin-treated diabetes patients had higher target lesion failure rates than non–insulin-treated diabetes patients. The results appear in JACC: Cardiovascular Interventions.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ